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INTRODUCTION
Implantation of pregnancy within a cesarean
section scar is considered to be the rarest form of
ectopic pregnancy and it was first reported by
Larsen and Soloman in 1978.1-3 But this is possibly
life-threatening condition because of the risk of
uterine rupture and massive hemorrhage.
Since the advent of trans-vaginal ultrasound, the
condition, which can be diagnosed earlier and
treated more conservatively and then we can avoid
hysterectomy and maintain fertility. Because of
the different condition of the tubal pregnancy and
cervical pregnancy, the treatment modalities
should be considered in different way. We report 4
cases of ectopic pregnancy in a cesarean scar
diagnosed by transvaginal ultrasound and treated
conservatively between the year of 2004 to 2005.
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A Cesarean section scar pregnancy is a rare but possibly life-threatening condition. The diagnosis is made mainly based on transvaginal
ultrasonography. We used the Doppler and serial HCG in determining the severity and prognosis. Because of the rarity, universalβ
treatment has not been established. In our cases, the severity of bleeding was independent of the level of HCG and the duration ofβ
amenorrhea. The shorter the interval from the previous cesarean section, the more severe the symptom, in such case, we were able to
preserve fertility by uterine artery embolization. Cesarean section scar pregnancy can be managed conservatively with methotrexate
injection. Based on our case review, we can conclude that it is very important that we choose the each therapeutic management based
on her history and condition. In our review, we present four cases diagnosed with Cesarean section scar pregnancy all managed
conservatively to preserve future fertility.
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A 30-year-old gravida 5, para 2, Rh-positive
woman was referred to us under the impression of
cervical pregnancy. She presented with heavy
vaginal bleeding for one day, after 5+5 weeks of
amenorrhea. She had undergone a second cesarean
delivery at term 5 years earlier and dilatation and
evacuation 4 years earlier. Her past medico-
surgical history was unremarkable. Physical
examination was unremarkable except for
moderate bleeding from the external cervical os.
Her pulse and blood pressure were normal.
Laboratory data revealed a quantitative serum
HCG level of 14864 mIU/mL. Transvaginalβ
ultrasonography demonstrated about 2.5 cm sized
heterogenous echogenic mass on the cesarean
section scar surrounded by thin myometrium below
the urinary bladder. Neither embryonic pole nor
fetal cardiac activity was detected. The uterine
cavity was empty. No fluid was seen in the cul-
de-sac. Based on the ultrasound findings, the
diagnosis of cesarean scar pregnancy was made
(Fig. 1). Management options were explained to
the patient. After discussion, the patient
underwent uterine artery embolization in an
attempt to decrease the known risk of continuous
vaginal bleeding with cesarean scar pregnancy. On
day 3, no remarkable bleeding was observed
after the intervention. Serum HCG level wasβ
7216 mIU/mL. Ultrasound-guided transcervical
aspiration was performed with a 22 gauge spinal
needle. Gestational sac contents were aspirated. A
single 50-mg dose of methotrexate (MTX) was
injected via intra-sac and no active hemorrhage
from the cervical cavity was observed.
Fig. 1. Gestational sac at previous Cesarean section scar.
On day 10, serum HCG level was 9184 mIU/mLβ
and transvaginal sonography showed slightly
enlarged uterus with about 2.7 cm sized
heterogenous echogenic mass on the cesarean
section scar. Despite the intervention, serum β
HCG level, the size of heterogenous echogenic
mass and A-V (Arterio-venous) malformation
pattern increased. On day 20, she was admitted
for treatment and surveillance. Serum HCG levelβ
was 3986 mIU/mL and ultrasonography showed a
persistent mass on the section scar. Doppler
evaluation revealed increased A-V malformation
(Fig. 2). MTX 1 mg/kg (68 kg, 6.8 mg) and
leukovorin 0.1 mg/kg for 8 days were administered
alternately via IM (intra-muscular). Liver and
renal function was regularly checked. No adverse
effect of methotrexate was noted.
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Fig. 2. Doppler ultrasongography shows increased A-V
malformation.
On day 27, serum HCG level was 2320 mIU/β
mL. On day 32, she presented to the emergency
room complaining of persistent vaginal bleeding.
Initial vital sign was stable and serum HCG levelβ
was 574 mIU/mL. Transvaginal sonography showed
persistent mass on cesarean scar but its location
was closer to the lower portion with decreased
blood flow compared to previous findings. On day
34, dilatation and evacuation was performed in an
attempt to decrease intrauterine content. Serum
HCG level was 62 mIU/mL. On day 49, serumβ β
HCG taken during a routine follow up at our out
patient clinic was undetectable and transvaginal
sonographic findings was also unremarkable.
2. CASE 2
A 38-year-old gravida 5, para 2, Rh-positive
woman was presented to us with heavy vaginal
bleeding after 11+0 weeks of amenorrhea.
Therapeutic dilatation and evacuation had been
performed under the impression of partial mole
at a private clinic. Four years earlier she had
undergone a lower segment transverse cesarean
delivery at term. She had 2 prior history of
dilatation and curettage. Her past medico-surgical
history was unremarkable. Her general physical
condition was normal and her vital signs were
stable. Gynecologic examination revealed moderate
vaginal bleeding. The serum HCG level was 1834β
mIU/mL. Transvaginal ultrasonography showed
about 2.6 2.3 cm sized heterogenous echogenic×
mass on the cesarean scar lesion surrounded by
thin endometrium. Neither embryonic pole nor
fetal cardiac activity was detected. The uterine
cavity was empty. No fluid was seen in the cul-
de-sac. Based upon the ultrasound findings,
the diagnosis of cesarean scar pregnancy was
made (Fig. 3). Uterine artery embolization was
performed in an attempt to decrease the known
high risk of hemorrhage with cesarean scar
pregnancy. The vital signs became stable and
vaginal bleeding decreased progressively. On day
2, transvaginal ultrasonography showed persistent
mass lesion and about 3.7 3 cm sized right×
ovarian cyst. On day 10, serum HCG was 694.8β
mIU/mL and transvaginal ultrasonography
revealed decreased mass size and persistent right
ovarian cyst. On day 14, she presented with
moderate vaginal bleeding. General physical
examination was normal and her vital signs were
stable. Gynecologic examination revealed mild
bleeding from cervical os. Serum HCG level wasβ
244.7 mIU/mL and transvaginal ultrasonography
showed about 2.3 2.3 cm sized heterogenous×
echogenic mass on the cesarean section scar
surrounded by thin endometrium. A-V malfor-
mation pattern decreased. After discussing the
best treatment modality forr this patient,
conservative management with rectal cytotec and
intravenous oxytocin infusion was chosen because
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patient s symptoms were mild. Blood loss was’
replaced with 2 units of packed RBC. She was
discharged from our institution because she was
clinically stable. On day 22, serum HCG takenβ
in our out patient clinic was 90.7 mIU/mL and
transvaginal ultrasonography showed no interval
change of previous findings. On day 31, serum β
HCG level was 2.1 mIU/mL and transvaginal
ultrasonography revealed decreased hypoechoic
mass of 1.8 cm on anterior wall and the same
sized right ovarian cyst. The margin was well
demarcated. On day 87, Doppler revealed no
abnormal findings (Fig. 4).
3. CASE 3
A 38-year-old gravida 6, para 2, Rh-positive
woman was referred to us under the impression of
cervical pregnancy from a private clinic with 5+6
weeks of amenorrhea. Ten years earlier she had
undergone a lower segment transverse cesarean
delivery at term. She had 3 prior histories of
dilatation and curettage. Her past medico-surgical
history was unremarkable. Her general physical
Fig. 3. Gestational sac at previous Casarean section scar.
condition was normal and her vital signs were
stable. Gynecologic examination was unremar-
kable. The initial serum HCG level was 27838β
mIU/mL. Transvaginal ultrasonography showed
about 0.8 cm sized gestational sac including 0.3
cm sized crown-rump, yolk sac, and fetal cardiac
activity (112 bpm) on the cesarean scar lesion. The
uterine cavity was empty (Fig. 5). No fluid was
seen in the cul-de-sac. Based upon the ultrasound
findings, the diagnosis of cesarean scar pregnancy
was made. MTX 1 mg/kg (75 kg, 75 mg) and
leukovorin 0.1 mg/kg were administered for 8 days
alternately via IM. Liver and renal function was
regularly checked. No adverse effect of MTX was
noted. On day 8, serum HCG level was 36108β
mIU/mL and disrupted G-sac was revealed on
transvaginal ultrasonography. On day 15, serum β
HCG level was 17713 mIU/mL and transvaginal
ultrasonography showed disrupted G-sac and loss
of fetal cardiac activity. The serial transvaginal
ultrasonography showed no interval change on
days 23 and 30. On day 32, despite the declining
values of serum HCG, the gestational sacβ
diameter remained the same. Conservative
Fig. 4. Doppler ultrasonography shows no abnormal ffindings.
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Fig. 5. Gestational sac at previous Cesarean section scar.
management with single dose of MTX 50 mg/m2 (50
mg 1.82, 90 mg) was administered intramu× -
scularily. No adverse effect of MTX was noted. She
was discharged from our institution because she
was clinically stable . Serial serum HCG levelβ
were 554 mIU/mL, 490 mIU/mL, 58 mIU/mL,
and 15.6 mIU/mL on days 36, 39, 42, 63 and
98 respectively.
4. CASE 4
A 41-year-old gravida 4, para 2, Rh-positive
woman was referred to us from a private clinic
under the impression of cervical pregnancy after
6+0 weeks of amenorrhea. Her initial presenting
symptom was heavy vaginal bleeding. Twelve years
earlier she had undergone a second lower segment
transverse cesarean deliveries at term. She had a
prior history of dilatation and curettage. Her past
medico-surgical history was unremarkable. Her
general physical condition was normal and her
vital signs were stable. Gynecologic examination
revealed moderate vaginal bleeding. The initial
serum HCG level was 11447 mIU/mL andβ
transvaginal ultrasonography showed about 0.8 cm
sized gestational sac including about 0.2 cm sized
yolk sac on the cesarean scar lesion surrounded by
thin endometrium.. The uterine cavity was empty.
No fluid was seen in the cul-de-sac. Based upon
the ultrasound findings, the diagnosis of cesarean
scar pregnancy was made. MTX 1 mg/kg and
leukovorin 0.1 mg/kg were administered for 8 days
alternately via IM. Liver and renal function was
regularly checked. No adverse effect of MTX was
noted. On the day 7, serum HCG level was 32925β
mIU/mL and transvaginal ultrasonography showed
about 1.4 cm sized gestational sac with about 0.4
cm sized yolk sac. We decided to discharge her and
have her visit our out patient clinic on regular
basis for routine follow up since she was clinically
stable with declining HCG values. On day 14,β
serum HCG level was 16697 mIU/mL andβ
transvaginal ultrasonography showed no interval
change. The serial serum HCG level were 7168β
mIU/mL, 4633 mIU/mL, 2901 mIU/mL, 2232 mIU/
mL, 1705 mIU/mL, 642 mIU/mL, 107 mIU/mL, and
9.5 mIU/mL on the days 21, 25, 28, 35, 42, 49, 63
and 87, respectively. On day 136, serum HCGβ
level was below 2.0 mIU/mL and transvaginal
ultrasonography showed no remarkable findings
other than minimal fluid collection in the
endometrium.
DISCUSSION
Based on previous case reports, initial
presenting symptoms of cesarean scar pregnancies
are acute abdominal pain and hypovolemic shock
due to massive and life threatening internal
hemorrhage (Table 1). Findings from life-saving
laparotomy include a sacculus of a ruptured
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uterus.4 The natural history of the cesarean scar
pregnancy is unknown since so few cases have
been reported in the literature. However, the
cesarean scar pregnancies are more common these
days, which may reflect the increasing number of
assisted reproduction. Trauma and scarring in the
endo- and myometrium can occur after cesarean
section, dilatation and curettage, myomectomy,
operative hysteroscope and manual removal
of placenta, which can create a favorable
implantation site in that area.5,6 Formation of a
microscopic dehiscent tract in the myometrium
Table 1. Summary for our cases
Age Presenting No. of HCGβ US Duration of Last cesarean No. No. No. Uterus Interval (days)
symptoms Admission (initial) findings amenorrhea section delivery/ of of of preserved from first to
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sized mass
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Case 3 38 VB
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2 - - Yes 98 days
sized mass
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Case 4 41 VB 1 11447 0.7 cm 6
+0














intra sac single dose injection
7)
Readmission after 14 days respectively due to recurrent bleeding
8)
D&E was performed under the impression of partial mole at a private clinic (amenorrhea 6 weeks)
9)
Readmission after 32 days for MTX treatment
10)
systemic single dose injection
after trauma to the uterus is one of the possible
pathogenesis for cesarean scar pregnancies but
other contributional factors need to be further
examined.7
Clinical diagnosis of an early pregnancy
implanted in a previous cesarean scar is very
difficult and need to be differentiated from
cervical pregnancy, cervicoisthmic pregnancy,
spontaneous abortion in progress and molar
pregnancy.8 The most important diagnostic tool
is transvaginal ultrasonography. Vial et al.
suggested the three most common sonographic
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findings to be i) the implantation of trophoblastic
tissue between the bladder and the anterior
uterine wall, ii) no fetal contents in the uterine
cavity, iii) discontinuity of the anterior wall of the
uterus from the sagittal view. If these criteria are
not enough in diagnosing cesarean scar pregnancy,
Magnetic resonance imaging (MRI) can be
effective.9 In addition, a prominent peritro-
phoblastic flow due to neovascularization by
ultrasound Doppler imaging can be helpful.10,11
Based on our case reviews, there are no significant
relationship among the Doppler imaging and the
level of HCG with the prognosis and severity of
the disease. However, it is somewhat premature to
determine and conclude the significance based on
few case reviews and further studies are needed.
As the pregnancy progress, the risk of uterine
rupture and life-threatening hemorrhage increase
and therefore termination of pregnancy must
be recommended to the patient. Two principle
management options may be considered, medical or
surgical. The surgical approach includes wedge
excision and evacuation of the gestational sac by
laparotomy and minilaparotomy and repair of the
cesarean section scar. However, often times, loss
of reproduction can result if hysterectomy is
performed due to massive bleeding from the
implantation site. Medical treatment is the
treatment of choice if the patient is
hemodynamically stable and when the patient
desires to retain her fertility. According to prior
studies, initial treatment with MTX is effective in
80% of the cases.12 MTX can be administered either
systemically or locally, however, direct local
injection of MTX into the gestational sac may
technically be difficult and often times rupture
of the uterus and heavy bleeding may follow.
However, since the incidence of cesarean scar
pregnancy is rare, the best management option,
either surgical or medical, is yet to be determined.
After systemic MTX administration, the
formation of connection of the chorion to the
cavum uteri is considered to be the natural history
of cesarean scar pregnancy.2 If vaginal bleeding
occurs after systemic MTX administration, it is
important to confirm the formation of this
connection by transvaginal ultrasonography or
MRI. Additional systemic MTX or dilatation and
curettage should be considered to remove this
connection of the chorion to the cavum uteri.
Based on our case review, it seems the duration
between the last cesarean delivery and the onset
of symptoms such as vaginal bleeding is important
in terms of recurrence and the severity of
bleeding. In two cases, bleeding severe enough to
require uterine artery embolization was more
frequent when the interval between the last
cesarean delivery and the onset of symptoms were
shorter (4 years vs. 10,12 years). In this case
review, there was no significant relationship
among the duration of amenorrhea, the number of
cesarean section the patient has undergone, initial
serum hCG level, ultrasound findings and the
severity of bleeding and recurrence.13 However,
further review and evaluation of similar cases are
needed to discuss the relationships between the
several factors mentioned above.
It took, on average, about 30-70 days for serum
hCG level to decline below 60 mIU/mL after
symptoms resolved, which is comparable to
previous case reports. Similar to previous case
reports, most of our patients were conservatively
managed with MTX (Table 2).
Based on our experience, we think that
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Table 2. Summary for previous cases
Age Presenting HCGβ US Duration of Last cesarean No. No. No. Uterus Interval (days)
symptoms (initial) findings amenorrhea section delivery/ of of of preserved from first to




UAE D&E last visit
section use
M. Arslan 32 Nausea >10000 3.5 mm 7 3
3)
YA/? - - 1 Yes 90 days




VB 6413 4 cm sized 8 ?/1 1 2 - Yes 120 days
Chou et al mass
Neovascul
arization
Michael T. 21 Abortion 21866 3.3 cm 8 5
5)
MA/? 1 - - Hysterotomy F/u loss
et al sized mass with uterine
FHB(+) preservation
Jesse 40 VB 7052 Scar ? ?/1 1 - - Vasopressin 30 days
Chuang pregnancy injection to
et al G-sac
Olivier 34 Abdominal 9585 2.3 cm 6 3YA/? 1 - - Yes 40 days
Graesslin pain sized mass
et al FHB(+)
Frank 31 Asymptomatic 45774 6.0×4.3 cm 8
+3
?/? 1 - - Yes 97 days
Nawroth Amenorrhea sized mass intra+IM
et al Strong circular
perfusion
Pierre-Arnaud 33 VB 62000 Implanted 6
+3
?/2 1 - - Yes 82 days













treatment for cesarean section scar pregnancy
should be similar to that of tubal pregnancy.14 The
pathogenesis, clinical manifestations, and imaging
studies of cesarean scar pregnancy and cervical
pregnancy are similar. However, in terms of
treatment, cesarean scar pregnancy should be
managed similar to that of tubal pregnancy. The
gestational sac of cervical pregnancy is located in
the fibrous wall of cervix where muscle is scarce
and the only surgical option is hysterectomy
because wedge resection could lead to life
threatening bleeding.12,14 However, wedge resection
of the gestational sac and repair of the fibrous
scar tissue in cesarean section scar pregnancies is
proven to be more effective based on previous case
reports.3,8
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In all 4 cases, patients were managed
expectantly without surgical intervention.
However, in some cases recurrent vaginal bleeding
occurred after expectant management and required
either uterine artery embolization15 and MTX
treatment which were both costly and time
consuming.16-19 From our experience, surgical
removal of the gestational sac and repair of
the fibrous scar tissue may help avoid such
complications and recurrence in the future.
However, because the implant may occur in the
vesico-uterine space of the bladder wall and the
cesarean section scar is surrounded by dense
fibrous scar tissue, injury to the surrounding
anatomy may occur. Thus, no single treatment
modality is entirely reliable and thus
treatment options should be based on each
patient's circumstances.19,20
Implantation of a pregnancy within a cesarean
section scar is rare and further case review and
research is needed. Current diagnostic tools enable
us to make an early detection of cesarean section
scar pregnancies and differentiate it from other
forms of ectopic pregnancies. Because of the rarity
of these cases, no universal treatment plan has
been established. Early detection and treatment is
important, however, further effort is needed to
establish the risk factors and focus on reducing
the number of cesarean section scar pregnancies
from occurring in the first place.
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통해서 진단한다 본 연구에서 질환의 정도나 예후결정에 도플러 초음파와 연속적인 값의 측정을 이용하였다. HCG .β
본질환은흔하지않은특성으로인해 보편적인치료방법은아직까지정립되어있지않다 금번연구에서이상질출혈의, .
정도는 값이나무월경기간과는무관하였다 증상의발현과이전의제왕절개기간이짧을수록증상은더욱심하HCG .β
였으며 이런경우자궁동맥색전술로임신력을보존할수있었다 제왕절개반흔임신은보존적으로 항암, . methotrexate
요법으로치료될수있었다 본연구에서환자의과거력과현재의상태에따른각각의치료방법을선택하는것이중요하.
다는결론을얻을수있었다 이에추후의임신력을유지하면서성공적인보존적치료가되었던제왕절개반흔임신의.
치료 예를 보고하는 바이다4 .
중심단어: 제왕절개 반흔 자궁외 임신 보존적 치료, ,
